Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS Jr, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators. McGarry A, et al. Among authors: de blieck ea. Neurology. 2017 Jan 10;88(2):152-159. doi: 10.1212/WNL.0000000000003478. Epub 2016 Dec 2. Neurology. 2017. PMID: 27913695 Free PMC article. Clinical Trial.
Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.
McGarry A, McDermott MP, Kieburtz K, Fung WLA, McCusker E, Peng J, de Blieck EA, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators. McGarry A, et al. Among authors: de blieck ea. Neurology. 2019 Apr 2;92(14):e1643-e1651. doi: 10.1212/WNL.0000000000007244. Epub 2019 Mar 8. Neurology. 2019. PMID: 30850442 Free PMC article.
Analysis of Participant Withdrawal in Huntington Disease Clinical Trials.
Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N. Banno H, et al. Among authors: de blieck ea. J Huntingtons Dis. 2017;6(2):149-156. doi: 10.3233/JHD-170246. J Huntingtons Dis. 2017. PMID: 28671136 Free PMC article.
A futility study of minocycline in Huntington's disease.
Huntington Study Group DOMINO Investigators. Huntington Study Group DOMINO Investigators. Mov Disord. 2010 Oct 15;25(13):2219-24. doi: 10.1002/mds.23236. Mov Disord. 2010. PMID: 20721920 Free PMC article. Clinical Trial.
Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects.
Huntington Study Group Pre2CARE Investigators; Hyson HC, Kieburtz K, Shoulson I, McDermott M, Ravina B, de Blieck EA, Cudkowicz ME, Ferrante RJ, Como P, Frank S, Zimmerman C, Cudkowicz ME, Ferrante K, Newhall K, Jennings D, Kelsey T, Walker F, Hunt V, Daigneault S, Goldstein M, Weber J, Watts A, Beal MF, Browne SE, Metakis LJ. Huntington Study Group Pre2CARE Investigators, et al. Among authors: de blieck ea. Mov Disord. 2010 Sep 15;25(12):1924-8. doi: 10.1002/mds.22408. Mov Disord. 2010. PMID: 20669312
Communicating clinical trial results to research participants.
Dorsey ER, Beck CA, Adams M, Chadwick G, de Blieck EA, McCallum C, Briner L, Deuel L, Clarke A, Stewart R, Shoulson I; Huntington Study Group TREND-HD Investigators. Dorsey ER, et al. Among authors: de blieck ea. Arch Neurol. 2008 Dec;65(12):1590-5. doi: 10.1001/archneurol.2008.503. Arch Neurol. 2008. PMID: 19064746
A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone).
Constantinescu R, McDermott MP, Dicenzo R, de Blieck EA, Hyson HC, Beal MF, Bednarczyk EM, Bogdanov M, Metakis LJ, Browne SE, Lorenzo BJ, Ravina B, Kieburtz K. Constantinescu R, et al. Among authors: de blieck ea. J Clin Pharmacol. 2007 Dec;47(12):1580-6. doi: 10.1177/0091270007307571. Epub 2007 Oct 9. J Clin Pharmacol. 2007. PMID: 17925590 Clinical Trial. No abstract available.
Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).
Kwon JM, Adams H, Rothberg PG, Augustine EF, Marshall FJ, Deblieck EA, Vierhile A, Beck CA, Newhouse NJ, Cialone J, Levy E, Ramirez-Montealegre D, Dure LS, Rose KR, Mink JW. Kwon JM, et al. Neurology. 2011 Nov 15;77(20):1801-7. doi: 10.1212/WNL.0b013e318237f649. Epub 2011 Oct 19. Neurology. 2011. PMID: 22013180 Free PMC article.
Analysis of Participant Withdrawal in Huntington Disease Clinical Trials.
Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N. Banno H, et al. Among authors: de blieck ea. J Huntingtons Dis. 2017;6(4):371. doi: 10.3233/JHD-179002. J Huntingtons Dis. 2017. PMID: 28922164 No abstract available.
27 results